LexBlog IP

DECEMBER 13, 2023

The post Janssen and Samsung Bioepis Settle STELARA (Ustekinumab) Litigation appeared first on Big Molecule Watch.

Litigation 52

Litigation Settlement Licensing Marketing 52

Technology & Marketing Law Blog

MARCH 25, 2024

If the case stands on appeal, Twitter will write a check to CCDH to compensate it for the litigation harms Twitter has imposed on it. The case relates to CCDH reports showing Twitter’s struggles with hate speech and misinformation following Musk’s changes to Twitter’s content moderation policies.

Litigation 85

Litigation Contracts Advertising Advertising 85

JD Supra Law

JULY 21, 2021

Is 3D printing the next litigation frontier? Litigation over 3D printing will become increasingly more prevalent as the technology becomes less expensive to build due to rising demand, some lawyers say. Defendant Jerrit Askvig is accused of manufacturing, distributing, marketing and selling an infringing product. The dispute.

Reporting 98

Reporting Litigation Technology Marketing 98

IP Watchdog

APRIL 23, 2023

The European Union is reportedly considering sweeping new regulations for the licensing and litigation of standard essential patents (SEPs), which make fair-minded observers wonder whether any sane adults are in charge at the European Commission (EC).

Patent 131

Patent Licensing Litigation Marketing 131

Intellectual Property Law Blog

SEPTEMBER 13, 2023

Investors and companies are pouring cash into the space, and particularly into generative AI (GAI), to seize their share of the market which McKinsey reports could add up to $4.4 A wave of litigations and enforcement actions has swelled. The use of artificial intelligence (AI) is booming. trillion annually to the global economy.

Government 147

Government Business Litigation Reporting 147

Technology & Marketing Law Blog

OCTOBER 8, 2022

However, usually, if plaintiffs could provide some evidence of notice that was consistent with how the original contract said it would update the terms, courts would give them the benefit of the doubt, at least at the early stages of litigation. Int’l Markets at 5. This was the key takeaway in Sifuentes v. Thayer , 2022 WL 4290310 (D.

Marketing 127

Marketing Marketing Contracts Business 127

43(B)log

OCTOBER 11, 2022

30, 2022) Pegasystems alleged that defendants, which compete with it in the business process management (BPM) software field, engaged in false advertising and commercial disparagement in an online report that portrayed Pegasystems unfavorably. Defendant BPM.com reported on the BPM industry. Previous discussion.)

Marketing 59

Marketing Marketing Business False Advertising 59

LexBlog IP

SEPTEMBER 22, 2023

We previously reported on patent infringement litigations between Alnylam and Moderna. Alynlam had previously alleged that Moderna’s COVID-19 vaccine products, marketed as SPIKEVAX® infringed U.S. Stay tuned to Big Molecule Watch for more updates on this litigation. ModernaTX, Inc., and Moderna US, Inc.

Litigation 52

Litigation Patent Patent Infringement Art 52

LexBlog IP

OCTOBER 25, 2023

As we previously reported , in July 2023 Genentech, Inc., collectively, “Genentech”) filed BPCIA litigation against Biogen MA Inc. On September 29, Biogen received FDA approval for its tocilizumab biosimilar, marketed as TOFIDENCE (tocilizumab-bavi). Hoffmann-LaRoche, Inc., and Chugai Pharmaceutical Co.,

Litigation 52

Litigation Settlement Reporting Marketing 52

LexBlog IP

MARCH 18, 2022

Indeed, one of us bloggers started at the FTC in 1998, and the first case he worked on was the agency’s litigation against R.J. ” Twenty years later, in 2019, when Chairman Simons was at the helm, the FTC initiated a study regarding the advertising and marketing methods being used by various electronic cigarette companies.

Reporting 52

Reporting Advertising Advertising Settlement 52

43(B)log

NOVEMBER 27, 2023

Marketing, Sales Practices & Products Liab. SoClean is a dominant player in the market for medical devices that sanitize continuous positive airway pressure machines (CPAPs), which treat sleep apnea and respiratory conditions. And, they continued, SoClean was illegally marketing its devices. In re SoClean, Inc.,

Advertising 59

Advertising Advertising Marketing Marketing 59

Velocity of Content

JULY 14, 2023

In recent weeks, Paul Tremblay, Mona Awad, Sarah Silverman, Christopher Golden, and Richard Kadrey have all filed litigation , “accusing the companies of using the authors’ copyrighted books without consent to ‘train’ their artificial intelligence software programs,” reports the Los Angeles Times.

Journalism 98

Journalism Copyright Infringement Litigation Copyright Law 98

The IPKat

SEPTEMBER 23, 2022

The winds of a busy Belgian court term blows through the IPKat's wild ancestor's mane (c) Christopher Stothers 'Tis the season for a look at the cases that were in 2021 from around Europe and what they mean for the IP litigation themes in those jurisdictions now that the dust has settled in 2022. The decisions we (arbitrarily!)

Litigation 82

Litigation Law Patent Invention 82

Technology & Marketing Law Blog

DECEMBER 5, 2022

Case Citation : Digital Marketing Advisors v. Universal. * Two 512(f) Rulings Where The Litigants Dispute Copyright Ownership. * It Takes a Default Judgment to Win a 17 USC 512(f) Case–Automattic v. The post 512(f) Plaintiff Must Pay $91k to the Defense–Digital Marketing v. McCandless Group, LLC, 2022 WL 17403067 (C.D.

Marketing 74

Marketing Marketing Cease and Desist Fair Use 74

LexBlog IP

JANUARY 8, 2024

As we have previously reported, in November 2023 Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed complaints against Celltrion, Samsung Bioepis and Formycon (collectively, “the Defendants”) in the U.S. Stay tuned to Big Molecule Watch for more updates on this litigation.

Litigation 52

Litigation Patent Infringement Reporting Marketing 52

The IPKat

MARCH 28, 2022

On 14-16 March, this GuestKat had the opportunity to attend the "Pharma & Biotech Patent Litigation" conference in Amsterdam, which, as many readers will know, not only hosts the Kattenkabinet museum (here below a sample of the oeuvres of the museum.), The IPKat reports on some of the trends and topics from the conference below.

Reporting 76

Reporting Litigation Patent Confidentiality 76

LexBlog IP

JUNE 29, 2023

As we previously reported , Biogen sued Sandoz and Polpharma (“Defendants”) in a BPCIA litigation related to Defendants’ natalizumab biosimilar. To demonstrate irreparable harm, Biogen pointed to harm in the form of (1) price erosion, (2) lost sales and market share, and (3) reputational harm.

Litigation 52

Litigation Marketing Marketing Patent 52

IAM Magazine

SEPTEMBER 22, 2021

The Long Read : Sector-by-sector analysis reveals that transport, financial services and networking all recorded triple-digit percentage growth in patent suits filed by non-practising entities between 2018 and 2020, writes IAM data reporter Bridget Diakun.

Litigation 94

Litigation Reporting Patent Marketing 94

IP Tech Blog

AUGUST 3, 2023

We anticipated that district courts would soon be addressing this decision in pending and future litigation. During the pre-trial conference held on July 13, 2023, the district judge ordered the parties to provide supplemental letter briefing regarding the impact of Abitron on the pending litigation. Hetronic International, Inc.

Litigation 52

Litigation Trademark Blogging IP 52

LexBlog IP

MAY 26, 2022

According to a report published in March 2022 by Global Market Insights Inc., the global market valuation for voice recognition technology will reach approximately $10 billion by 2028. However, as more companies implement these technologies, the risk of litigation for failure to comply with biometrics laws increases.

Litigation 40

Litigation Privacy Technology Marketing 40

LexBlog IP

AUGUST 3, 2023

We anticipated that district courts would soon be addressing this decision in pending and future litigation. During the pre-trial conference held on July 13, 2023, the district judge ordered the parties to provide supplemental letter briefing regarding the impact of Abitron on the pending litigation. Hetronic International, Inc.

Litigation 52

Litigation Trademark Reporting Marketing 52

LexBlog IP

SEPTEMBER 28, 2021

As we previously reported , AbbVie Inc. (“AbbVie”) brought an action on April 27, 2021, in the Northern District of Illinois for patent infringement against Alvotech hf. Litigation of the other patents asserted by AbbVie is stayed. ” The parties will file a joint written status report by January 7, 2022.

Litigation 40

Litigation Reporting Patent Application Patent Infringement 40

IP Watchdog

DECEMBER 19, 2023

Scott Hargis is an architectural photographer who sued Pacifica Senior Living Management LLC in September 2022 for damages and injunctive relief related to infringement of 43 of Hargis’ photos that Pacifica used to advertise and market its senior living facilities.

Copyright 104

Copyright Advertising Advertising Reporting 104

The IPKat

MARCH 24, 2024

Horology is however a market steeped in history with its own unwritten rules and customs. It is famously a market where supply and demand is meticulously controlled by the big watchmakers and consciously kept misaligned. It is not enough for you to simply have the money to buy your long sought grail watch from the likes of F.P.

IP 70

IP Marketing Marketing Reporting 70

Technology & Marketing Law Blog

MAY 13, 2024

But by providing a foil in litigation against both the Center for Countering Digital Hate (“CCDH”) and Bright Data (the world’s largest seller of scraped data), he’s given judges in the most important district court in the country for tech legal issues, the Northern District of California, plenty of motivation to rule against him.

Blogging 94

Blogging Contracts Cease and Desist Social Media 94

LexBlog IP

SEPTEMBER 13, 2023

Investors and companies are pouring cash into the space, and particularly into generative AI (GAI), to seize their share of the market which McKinsey reports could add up to $4.4 A wave of litigations and enforcement actions has swelled. The use of artificial intelligence (AI) is booming. trillion annually to the global economy.

Government 52

Government Business Litigation Reporting 52

LexBlog IP

MARCH 6, 2023

With the increased funding pouring into this sector has come a desire to protect the intellectual property in the products, research, and developments brought to market. is currently available by request from the court reporter. See our colleague’s impressions from the 2022 MJ BizCon cannabis conference here.

Litigation 52

Litigation Patent Design Patent Patent Application 52

LexBlog IP

JANUARY 17, 2024

This is the first BPCIA litigation involving a eculizumab biosimilar. Alexion alleges that Samsung submitted its aBLA for SB12 to the FDA on July 7, 2023 and that same day, also provided Notice of Commercial Marketing pursuant to 42 U.S.C. § Stay tuned to Big Molecule Watch for more updates on this litigation.

Litigation 52

Litigation Marketing Marketing Reporting 52

The IPKat

FEBRUARY 6, 2023

Image by Pixabay Copyright Nedim reported the words of Katfriends Adrian Aronsson-Storrier and Oliver Faihurst, from Lewis Silkin, on the litigation commenced by Getty against the developers of the AI image generation software, Stability AI. Here is the latest recap of the posts written by the Kats since the last Never Too Late post.

Art 67

Art Reporting Copyright Law Copyright 67

IAM Magazine

DECEMBER 10, 2021

Three-quarters of IP market leaders in latest IAM Panel Report say they’re taking a cautious approach to the venue, which passed another key milestone for establishment last week.

Marketing 92

Marketing Marketing Reporting IP 92

IP and Legal Filings

JANUARY 2, 2024

Financial intermediaries like banks and stock markets provided loans and facilitated share capital inflow and trading. However, start-ups often start with high costs and limited revenue, making it difficult for them to mobilize capital from traditional channels like the stock market or financial institutions. 100 Crores.

Business 78

Business Reporting Marketing Marketing 78

IAM Magazine

SEPTEMBER 22, 2021

The Long Read : Sector-by-sector analysis reveals that transport, financial services and networking all recorded triple-digit percentage growth in patent suits filed by non-practising entities between 2018 and 2020, writes IAM data reporter Bridget Diakun.

Litigation 40

Litigation Reporting Patent Marketing 40

Technology & Marketing Law Blog

NOVEMBER 29, 2021

Candeub Report. The brief relies heavily on an “expert” report from Adam Candeub. Life is too short to spend precious time reading the report, though I did find the plaintiffs’ motion to strike interesting. All of the submitters are repeat players from the Florida litigation. Amicus Briefs. RCFP et al.

Social Media 112

Social Media Law Television Reporting 112

The IPKat

MARCH 24, 2022

The purpose of the SPC Regulations ( Regulation (EC) No 469/2009 and Regulation (EC) No 1610/96 ) is to compensate patentees for the lengthy process of achieving marketing authorisation for a medicinal or plant product. SPCs are national rights that provide an additional period of protection for a medicinal product protected by a patent.

Registration 82

Registration Reporting Marketing Marketing 82

IPilogue

JANUARY 24, 2022

I was fortunate to have a patient and knowledgeable supervisor in Ben Gray with whom to discuss a number of patent issues involving litigation strategy, biologics, skinny labeling, and means by which pharmaceutical companies seek to extend their commercial monopolies.

Intellectual Property 81

Intellectual Property Branding Brands Branding 81

The IPKat

AUGUST 8, 2022

Competition and market functioning 3. SEP litigation Overall, the responses from both SEP holders and implementers reported problems related to the efficiency or effectiveness of the ecosystem around SEPs. Transparency in the system 4. Patent infringement and remedies 5. Licensing of SEPs 6. Full press release here.]

Government 93

Government Publishing Patent Reporting 93

LexBlog IP

MARCH 10, 2022

The announcement states that under the settlement agreement, Alvotech has non-exclusive rights to market AVT02 in the United States starting July 1, 2023. ” The announcement further states that FDA has deferred action on Alvotech’s BLA until necessary inspections are completed. .”

Patent 52

Patent Settlement Litigation Patent Infringement 52